AAMU
CMTA

Amundi Asset Management US’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Amundi Asset Management US’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,600
Closed -$61K – 1673
2018
Q2 		$61K Hold
4,600
– – ﹤0.01% 1506
2018
Q1 		$70K Hold
4,600
– – ﹤0.01% 1460
2017
Q4 		$87K Buy
+4,600
New +$77K ﹤0.01% 1443

Other funds holding CMTA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Amundi Asset Management US's CMTA Position: Q3 2018 in Review

Amundi Asset Management US sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q3 2018, closing a stake of 4,600 shares — an estimated $61K sold.

Amundi Asset Management US first reported a position in CMTA in Q4 2017 and held it in 3 quarters. The position peaked at $87K in Q4 2017. 27 funds tracked by Wall St. Rank hold CMTA as of Q3 2018.

  • Amundi Asset Management US reported no remaining Clementia Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 4,600 Clementia Pharmaceuticals Inc. shares in Q3 2018, an estimated $61K.
  • Amundi Asset Management US first reported a position in Clementia Pharmaceuticals Inc. in Q4 2017 and held it in 3 quarters.
  • Amundi Asset Management US's Clementia Pharmaceuticals Inc. position peaked at $87K in Q4 2017.
  • 27 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q3 2018.

Based on Amundi Asset Management US's 13F filing for Q3 2018, filed 14 Nov 2018.